Towards Healthcare
APAC Central Lab Market to Lead USD 1085 Mn by 2034

APAC Central Lab Market Expansion and Technological Advances

According to market projections, the global APAC central lab market, valued at USD 622 million in 2024, is anticipated to reach USD 1085 million by 2034, growing at a CAGR of 5.72% over the next decade. The market is expanding as pharmaceutical and biotech companies increasingly rely on specialized labs for accurate, efficient, and standardized testing. In APAC, growth is fueled by rising investment in clinical research, supportive government initiatives, and expanding contract research organizations, with China and Japan emerging as key contributors.

Content

  • Insight Code: 6291
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The APAC central lab market stands at USD 658 million in 2025 and is expected to reach USD 1085 million by 2034, growing at a CAGR of 5.72% from 2024 to 2034.

China is currently leading the APAC central lab market due to emerging as a hub for specialized and high-throughput laboratory services.

Charles River Laboratories, Medpace, Frontage Laboratories, SGS S.A., Eurofins Scientific, REPROCELL Inc. 

Labs must comply with local regulations and international standards to ensure quality, safety, and data integrity.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions